The latest financial statement is for the year ending 2025-12-31.
| Cash Flow | 2025-12-31 |
|---|---|
| Net income (loss) | -2,929 |
| Share-based compensation | 7,050 |
| Depreciation and amortization | 14,231 |
| Impairment loss on goodwill and indefinite-lived intangible assets | 700 |
| Impairment loss on long-lived assets | 36 |
| Impairment loss on other investments | 0 |
| Loss from investments | -446 |
| Changes in expected credit losses on long-term financial assets | 4,859 |
| Revaluation of equity method investment | 0 |
| Revaluation of loan receivable | 0 |
| Loss on held-for-sale assets | 5,532 |
| Inventory step-up recorded to cost of sales | 517 |
| Foreign currency (gain) loss | -28,588 |
| Other non-cash operating activities, net | -1,250 |
| Accounts receivable, net | 16,741 |
| Interest receivable | 11 |
| Other receivables | 9,001 |
| Prepaids and other current assets | 1,802 |
| Inventory, net | 10,395 |
| Accounts payable | 1,108 |
| Income taxes payable | -10 |
| Accrued liabilities | 2,438 |
| Net cash provided by (used in) operating activities | 25,866 |
| Purchase of short-term investments | 40,000 |
| Proceeds from short-term investments | 0 |
| Purchase of other investments | 5,107 |
| Proceeds from sale of held for sale assets | 2,847 |
| Cash acquired in business combination | 0 |
| Advances on loans receivable | 13,307 |
| Proceeds from repayment on loans receivable | 5,064 |
| Dividends received from equity method investment | 0 |
| Dividend proceeds | 0 |
| Purchase of property, plant and equipment | 25,717 |
| Purchase of intangible assets, net of disposals | 339 |
| Other investing activities | 0 |
| Net cash provided by (used in) investing activities | -76,559 |
| Repurchases of common stock | 9,741 |
| Dividend paid to non-controlling interest | 6,413 |
| Withholding taxes paid on share-based awards | 3,751 |
| Net cash used in financing activities | -19,905 |
| Effect of foreign currency translation on cash and cash equivalents | 3,587 |
| Net change in cash and cash equivalents | -67,011 |
| Cash and cash equivalents, beginning of period | 858,805 |
| Cash and cash equivalents, end of period | 791,794 |
Cronos Group Inc. (CRON)
Cronos Group Inc. (CRON)